Eurican vaccination with rabies. Vaccine against deadly diseases in dogs: indications, side effects

INSTRUCTIONS
on the use of the vaccine Eurican DHPPi2-LR (Eurican DHPPi2-LR)

1. General information:

1.1 Trade name: Eurikan DHPPi2-LR ( Eurican DHPPi2-LR)

International non-proprietary name: vaccine against distemper, adenovirus, parvovirus, parainfluenza-2, leptospirosis and canine rabies.

1.2 Dosage form: lyophilized tablet (dry weight - live vaccine Eurican DHPPI2) and liquid component (inactivated vaccine Eurikan–LR) for the preparation of a suspension for injection.

Eurican DHPPI2 is made from culture fluids of cell cultures infected with attenuated strains of canine distemper virus, adenovirus CAV 2, parvovirus and canine parainfluenza-2 virus with the addition of polypeptides (22.5 mg/dose) and glucides (77.5 mg/dose) as stabilizers.

Eurikan–LR made from a suspension of inactivated leptospira serogroups Leptospira icterohaemorrhagiae and Leptospira canicola, rabies virus glycoproteins, ( strain G52), with the addition of aluminum hydroxide (0.6 mg) as an adjuvant.

Vaccine components Eurikan DHPPi2-LR packaged in 1 immunizing dose (1 ml) in glass vials of appropriate capacity, hermetically sealed with rubber stoppers reinforced with aluminum caps.

1.3 Vaccine vials are packed in plastic boxes of 10 or 50 immunizing doses.
Instructions for its use are included in each box with the vaccine.
Shelf life of the vaccine is 24 months from the date of issue, subject to the conditions of storage and transportation. After the expiration date, the vaccine is not suitable for use.

1.4 The vaccine is stored and transported in a dry, dark place at a temperature of 2 to 8C.
The vaccine must not be frozen.

1.5 The vaccine should be kept out of the reach of children.

1.6 Vials with a vaccine without labels, expired, with a violation of the integrity and / or tightness of the closure, with a changed color and / or consistency of the contents, with the presence of foreign impurities are subject to rejection and disinfection by boiling for 10 minutes.
Disposal of a decontaminated vaccine does not require special precautions.

2. Biological properties

2.1 Vaccine Eurikan DHPPi2-LR causes the formation of an immune response in dogs against the pathogens of canine distemper, infectious hepatitis, parvovirus, parainfluenza-2, leptospirosis and rabies 14 days after vaccination, lasting at least 12 months.

One immunizing dose (1 ml) contains at least 104.0CCID50 of attenuated plague virus; at least 102.5CCID50 of attenuated canine adenovirus ( CAV 2); at least 104.9CCID50 of attenuated canine parvovirus; at least 104.7CCID50 of attenuated canine parainfluenza virus type 2, inactivated Leptospira icterohaemorrhagiae and Leptospira canicola; at least 1 IU of rabies virus glycoproteins ( strain G52).

The vaccine is harmless, has no medicinal properties.

3. Application procedure

3.1 Vaccine Eurican DHPPi2-LR is intended for immunization of dogs against distemper, infectious hepatitis, parvovirus, parainfluenza-2, leptospirosis and rabies.

3.2 It is forbidden to vaccinate clinically ill and/or debilitated animals. Dogs should be de-wormed 10 days prior to vaccination. Pregnant bitches should be vaccinated during the first third of pregnancy.

3.3 vaccine Eurikan DHPPi2-LR administered subcutaneously in the area of the scapula, from 12 weeks of age, 3-5 weeks before or after the introduction of the vaccine DHPPI2-L, at a dose of 1 ml, regardless of body weight and breed of dog.
Revaccination is carried out annually at the same dose.

When vaccinating, it is necessary to follow the rules of asepsis and antisepsis. Before vaccination, the lyophilized component of the vaccine Eurican DHPPI2 combined with liquid component Eurikan–LR.
To do this, the liquid component of the vaccine is shaken and transferred with a sterile syringe into a vial with a lyophilized component, mixed until completely dissolved. The drug prepared in this way must be used immediately.

3.4 Symptoms of the manifestation of plague, adenoviruses, parvovirosis, parainfluenza-2, leptospirosis and rabies in dogs or other pathological signs in case of an overdose of the vaccine have not been established.

3.5 Features of the post-vaccination reaction during primary and subsequent immunizations have not been established.

3.6 Violations of the vaccination schedule should be avoided, as this may lead to a decrease in the effectiveness of immunoprophylaxis for distemper, adenoviruses, parvovirosis, parainfluenza-2, leptospirosis and canine rabies. In case of missing the next injection, it is necessary to carry out immunization as soon as possible.

3.7 A rapidly disappearing swelling may appear at the injection site. If an anaphylactic reaction occurs, symptomatic treatment is carried out.

3.8 Vaccine is not allowed Eurikan DHPPi2-LR simultaneously with other vaccines and drugs of other groups.

EURIKAN DHPPi + LR against canine distemper, parvovirus enteritis, infectious hepatitis, parainfluenza, leptospirosis and canine rabies, MERIAL, France

Description:

Eurikan DHPPI2 - LR "- vaccine against distemper, adenovirus, parvovirus, parainfluenza type 2, leptospirosis and rabies in dogs.

General provisions:

1.1. The vaccine against distemper, adenovirus, parvovirus, parainfluenza, leptospirosis and rabies in dogs "Eurikan DHPPI2-LR" consists of two components:

Lyophilized vaccine "Eurikan DHPPI2", which is a mixture of attenuated strains of canine distemper virus, adenovirus type 2, parvovirus and parainfluenza virus type 2 dogs.

The vaccine in appearance is a dry homogeneous porous mass of white color - liquid vaccine "Eurikan-LR" containing an inactivated rabies virus and inactivated leptospira serogroups Icterrhohemorrhagia and Canicola.

The vaccine in appearance is a colorless transparent liquid.

1.2. The components of the Eurikan DHPPI2-LR vaccine are packaged in 1 ml glass vials (1 dose).

The vials are sealed with rubber stoppers and run in with aluminum caps.

Each vial is provided with a label indicating: the name of the manufacturer and its trademark, the name of the vaccine, its volume, method of administration, batch number, expiration date.

1.3. The vaccine is packaged in cardboard or plastic boxes: - 100 vials of Eurikan DHPPI2 and Eurikan-LR vaccines or - 10 vials of Eurikan DHPPI2 and Eurikan-LR vaccines.

Each box contains instructions on how to use the vaccine.

1.4. A label is applied to the boxes, which indicate: the name and trademark of the manufacturer, the name of the vaccine, its volume, method of administration, batch number, expiration date.

1.5. The drug is stored at a temperature of 2 to 8 ° C in a dry, dark place.

Under the specified storage conditions, the shelf life of the drug is 24 months from the date of manufacture.

1.6. Vials with broken capping, mold, mechanical impurities, subjected to freezing are discarded and disinfected by boiling for 10 minutes.

2. Biological properties of the vaccine

2.1. The Eurican DHPPI2-LR vaccine induces the production of specific antibodies against distemper virus, type 2 adenovirus, parvovirus, type 2 parainfluenza virus, leptospirosis and rabies in dogs.

2.2. The vaccine is harmless, areactogenic.

2.3. Immunity is formed on 14-21 days. after the 1st vaccination.

The duration of immunity is at least 12 months.

3. The order of application of the vaccine

3.1. The Eurikan DHPPI2-LR vaccine is used to prevent distemper, adenovirus, parvovirus, parainfluenza, leptospirosis and rabies in dogs.

3.2. Vaccine "Eurican DHPPI2-LR" vaccinate only healthy animals, free from helminths.

3.3. When vaccinating, it is necessary to follow the rules of asepsis and antisepsis and use only sterile materials and instruments for injection.

3.4. Before vaccination, a mixture is prepared by mixing the Eurican DHPPI2 lyophilized vaccine with the Eurican-LR liquid vaccine, for which the liquid vaccine is collected with a sterile syringe, the stopper is punctured with a needle, injected into the vial with the lyophilized vaccine and shaken thoroughly.

It's no secret that four-legged pets get sick no less than their owners. Unfortunately, the ailments of dogs and cats in most cases are quite serious. In order to save a friend, you must act quickly and coolly. Let's see what the Eurikan vaccine is for, what effect it has, and what diseases it is aimed at treating.

"Eurikan": description

"Eurikan" is a complex hexavalent vaccine. The composition of the drug is two-component. It includes:

"Eurikan" DHPPI2 is a lyophilized vaccine aimed at combating canine distemper, parvovirus, adenovirus, as well as type 2 parainfluenza in dogs.
Eurikan RL is a liquid vaccine. Contains in an inactivated form, as well as leptospira serogroups Canicola and Interohemorrhagia.

There is also another type of vaccine on the market. Instead of "Eurikan" RL, it contains "Eurikan" L in its composition. The difference between this liquid component and the one mentioned earlier is that it does not contain an inactivated rabies virus. Therefore, when vaccinated with such a drug, the dog does not acquire immunity from this dangerous disease.

Indications for the use of the vaccine

What diseases is Eurikan used for? Instructions for use reveals the purpose of the drug:

Canine distemper is a viral disease that manifests itself in an extensive lesion of the dog's skin in conjunction with fever, damage to the nervous system and gastrointestinal tract. In addition, the course of the disease is often complicated by pneumonia. Puppies are especially susceptible to the plague of carnivores, but infection in adulthood is not ruled out.
Adenovirus infection is a contagious disease that affects the larynx, bronchi and trachea. Signs of the disease are cough, nasal discharge, fever, vomiting spasms, as well as intestinal and stomach disorders. Symptoms such as shortness of breath and decreased activity of the dog are also not uncommon.
Parvovirus infection - has two forms of manifestation: intestinal and cardiac. Symptoms of the first variety are fever, diarrhea, vomiting, inflammation of the mucous membranes, and abdominal pain. With a cardiac form of infection, the muscles of the heart are damaged.
Parainfluenza type 2 - affects the upper respiratory tract. Manifested in the form of tonsillitis, cough, serous discharge from the nose. Sometimes there is vomiting. At the same time, the dog's appetite does not worsen.
Leptospirosis is an infectious disease that poses a danger not only to the pet, but also to its owner. Runs covertly. Does not show any clinical signs. The pathogen, entering the body of a dog, causes damage to the liver, kidneys and mucous membranes, fever, jaundice, and dysfunction of the central nervous system. The incubation period does not exceed 15 days. Leptospirosis leads to the inevitable death of the animal.

Contraindications and side effects

Contraindications to the use of the vaccine in an animal are: the following factors:

Do not use in already infected dogs.
Defeat by helminths. In the case of deworming, vaccination is recommended no earlier than 10 days after the procedure.

Like any other drug, Eurikan also has some side effects. Instructions for use for dogs warns of possible swelling at the injection site. In rare cases, an allergic reaction is not excluded, requiring subsequent symptomatic treatment. "Eurikan" activates the production of antibodies specific to the previously mentioned viruses. Pet immunity is formed already on the 21st day after vaccination. And the protective effect persists throughout the year.

"Eurikan": instructions for use, manufacturer

The medicine is produced in France by the pharmaceutical company Merial. Before vaccination, a mixture must be prepared from the two components that make up the preparation. In this case, it is necessary to follow the rules of antiseptics, use only sterile materials. The injection dose, regardless of the weight and age of the animal, is 1 ml. It is recommended that the first vaccination be carried out at the 7th week of the dog's life, the second one - after three to five weeks.

"Eurikan" for puppies: instructions for use

One of the main questions is the possibility of using the vaccine for puppies. After all, most viral infections occur in childhood. So, is Eurikan safe in this case? Instructions for use allow vaccination of an animal from 3 months. The drug is safe and easily tolerated by the puppy, without causing side effects.

In addition, the use of the vaccine is possible even in pregnant females. Neither abortions, nor a decrease in the number of litters, nor other local and systemic reactions are observed in females. The main condition is sterility in the preparation of the solution, as well as the health of the animal. In the presence of symptoms of infection, the vaccine can aggravate the situation and lead to the inevitable death of the dog. Pay attention to the health of your pets and carry out the prevention of dangerous diseases in time.

7 January 2015

Timely prevention helps to avoid the occurrence of epidemics and the wide spread of deadly diseases such as enteritis or plague. Vaccination against rabies is mandatory for all dogs and cats living in settlements, as this disease is dangerous for humans and other carnivores. Which vaccine is superior to the rest in terms of protection and which is better for dogs: this question is of interest to all owners of purebred animals.

What is vaccination

Vaccination is a procedure for artificially infecting an individual in order to develop immunity to a specific disease. It is known that once having been ill with plague, enteritis or another viral disease, a dog acquires resistance to the disease for a certain period of time and subsequent infection, if possible, then in a mild form, even in case of close contact with a sick animal.

Antibodies that are produced when a virus appears in the body react immediately during subsequent attacks, killing the pathogen. A vaccinated dog, even after close contact with a virus carrier, does not get sick; in rare cases, the disease proceeds secretly, without obvious clinical signs.

The best vaccines for dogs are designed to form stable immunity, the use of which allows you to create confident protection against viruses and avoid various side effects. Many professional breeders and nursery owners, after many years of growing healthy livestock, prefer foreign-made vaccines NOBIVAK RL, EURIKAN LR and RABIZIN.

Vaccine Nobivak for dogs

Nobivak is an imported vaccine manufactured in the Netherlands and has high efficiency and recognition by international veterinary experts. Permanent immunity in adult animals is developed within two weeks after vaccination and lasts for at least a year.

The manufacturer Intervet International produces a whole series of vaccines with the trade name Nobivak intended for dogs. It includes:

Nobivac Puppy DP is the best immunization for puppies. It protects against distemper and parvovirus enteritis in very young puppies, starting from 4-6 weeks. At this age, maternal antibodies transmitted with colostrum are still quite strong, therefore, for confident immunity, it is recommended to carry out two more vaccinations before the age of four months;
Nobivac DHPPi is the most commonly used vaccination for puppies from ten weeks of age and adult animals. It can be combined with the leptospirosis or rabies vaccine of the same name. Immunity is formed quickly and lasts a year.
Monovalent vaccines Nobivak r (rabies) and Nobivak L (leptospirosis), they are most often used in combination with a polyvalent vaccine. Since the rabies vaccination is mandatory for all dogs from the age of three months, it is quite possible to use it separately, before the show season or travel.
Nobivak KS protects against parainfluenza and bordetellosis, it is recommended from two weeks of age. Especially for dogs, the instruction provides for the intranasal route of administration.

Vaccine Eurikan for dogs

The French company "Merial" produces a series of vaccines with the trade name "Eurican". Two species are actively used in the series, which are almost identical and differ only in the presence of the rabies component.

Eurikan DHPPI+2L can be used for dogs and immunization of puppies from eight weeks old, revaccination with a preparation containing a rabies vaccine is mandatory. For adult dogs vaccinated for the first time, revaccination is needed to acquire stable immunity, in the future, the vaccination is done once with an interval of twelve months.

Vaccination for puppies from three months and for dogs eurikan DHPPI+2LR protects animals from most deadly diseases: plague, enteritis, hepatitis, leptospirosis, parainfluenza and rabies.

Rabizin

Rabizin or "Rabisin-R" for dogs is produced by the manufacturer of Eurican in France and is a fairly effective and harmless vaccine against a deadly disease. Rabizin can be used for puppies from the age of three months, adult dogs and even pregnant bitches. The drug does not have a teratogenic effect, forms a stable immunity in two weeks.

Rules for the use of vaccines

Any vaccine can cause an allergic reaction that can range from mild discomfort to anaphylactic shock. Dogs prone to allergic reactions are advised to undergo special training. All animals must be dewormed ten days before vaccination.

After vaccination, it is advisable not to overload the dog with training, to minimize various stressful situations. In the first two weeks, the animal's body is weakened, and with hypothermia or stress, the pet may get sick.

COMPOSITION AND FORM OF RELEASE

Suspension for injection, prepared immediately before administration from two components: lyophilized - "DHPPI2" and liquid - "Eurikan-LR".

Eurican DHPPI; is made from culture liquids of cell cultures infected with attenuated strains of canine distemper virus, CAV2 adenovirus, parvovirus and canine parainfluenza-2 virus with the addition of drying medium as a stabilizer. Eurican-LR is made from inactivated leptospira serogroups Leptospira icterohaemorrhagiae and Leptospira canicola, rabies virus glycoproteins, strain G52, with the addition of aluminum hydroxide as an adjuvant.

The lyophilized component of the vaccine in appearance is a dry homogeneous porous mass of beige color, the liquid component is a colorless liquid with a white precipitate that forms a homogeneous suspension when shaken
The components of the Eurikan DHPPI.-LR vaccine are packaged in 1 inoculation dose (1 cm3) in glass vials of the appropriate capacity, hermetically sealed with rubber stoppers reinforced with aluminum caps.

PHARMACOLOGICAL PROPERTIES

Eurican DHPPL-LR vaccine induces an immune response in dogs against canine distemper, infectious hepatitis, parvovirus, parainfluenza-2, leptospirosis and rabies 14 days after vaccination, lasting less than 12 months. One immune dose contains:

Attenuated plague virus;

Attenuated canine adenovirus (CAV2);

Attenuated canine parvovirus;

Attenuated canine parainfluenza virus type 2;

Inactivated Leptospira icterohaemorrhagiae, inactivated Leptospira canicola, qs to provide protection according to the European Pharmacopoeia;

Rabies virus glycoproteins, strain G52.

The vaccine is harmless, has no medicinal properties.

INDICATIONS

The Eurikan DHPPI2-LR vaccine is used to prevent distemper, infectious hepatitis, parvovirus, parainfluenza, leptospirosis and rabies in dogs.

Vaccinate only healthy animals, free from helminths.

DOSES AND METHOD OF APPLICATION

When vaccinating, it is necessary to follow the rules of asepsis and antisepsis and use only sterile materials and instruments for injection.

Before vaccination, a mixture is prepared by mixing the Eurican DHP-PI2 lyophilized vaccine with the Eurican-LR liquid vaccine, for which the liquid vaccine is collected with a sterile syringe, the stopper is punctured with a needle, injected into the vial with the lyophilized vaccine and shaken thoroughly. The dissolved vaccine must be used immediately.

The vaccine "Eurican DHPPI2-LR" is administered at a dose of 1 ml (1 dose) subcutaneously into the scapular area or intramuscularly into the thigh area, regardless of the weight and breed of the dog, the vaccination program includes:

1st vaccination at 3 months of age

Revaccination in a year.

Combinations with other vaccines of the Eurikan group are possible.

In an unfavorable epizootic situation, vaccination against leptospirosis is recommended once every six months.

SIDE EFFECTS

At the injection site, a rapidly disappearing swelling is sometimes possible. In exceptional cases, an anaphylactic reaction is possible. In this case, symptomatic treatment is carried out.

CONTRAINDICATIONS

Individual sensitivity to the components of the drug.

SPECIAL INSTRUCTIONS

Vials (syringes) with broken closures, mold, mechanical impurities, subjected to freezing are discarded and disinfected by boiling for 10 minutes.

STORAGE CONDITIONS

The drug is stored at a temperature of 2 to 8 ° C in a dry, dark place. Under these conditions, the shelf life of the drug is 24 months from the date of manufacture.